Virginia (202) 466-6937 | Arizona (602) 388-8899

Legal Events



PLEASE NOTE: THE DECISIONS PUBLISHED ON THIS WEB SITE ARE NOT AN ALL-INCLUSIVE LISTING OF ALL CASES INVOLVING EMORD AND ASSOCIATES AS COUNSEL. RESULTS DEPEND UPON A VARIETY OF FACTORS UNIQUE TO EACH CASE. THE RESULTS PUBLISHED HERE DO NOT GUARANTEE OR PREDICT A SIMILAR RESULT IN ANY FUTURE CASE UNDERTAKEN BY THE FIRM.

The following includes a representative sample of recent decisions, pleadings, and presentations.

LEGAL DECISIONS:

Albion International, Inc. v. AIC, et al, Memorandum Decision re Laches

Alliance for Natural Health US v. Sebelius, et al.

In re ECM Biofilms, Inc. FTC Docket No. 9358 AL Initial Decision Jan 28, 2015)

Novelty Distributors, Inc.: Revocation of Registration (DEA)

Novelty v. DEA

Nutraceutical Corp. v. Von Eschenbach

Nutraceutical Corp. v. Crawford

Pearson v. Shalala

Pearson v. Shalala, en banc

Pearson v. Shalala II

Pearson v. Thompson

U.S. Citizens Association, et al. v. Kathleen Sebelius, et al.

Whitaker v. Thompson I

Whitaker v. Thompson II

Whitaker v. Thompson III

COMPLAINTS:

FDA Antioxidant Qualified Health Claim Complaint

FDA CGMP Complaint

FDA Selenium Qualified Health Claim Complaint

Saw Palmetto / BPH Complaint

B-Vitamin / Vascular Disease and E-Vitamin / Heart Disease Complaint

Medicinal Marijuana Complaint

Folic Acid Complaint Antioxidant Complaint

BRIEFS:

Opposition to Motion to Dismiss in Health Reform Case

Novelty Petition for Writ of Certiorari

Antioxidant Qualified Health Claims / Memorandum in Support of Motion for Summary Judgment

Nutraceutical Corp. v. Von Eschenbach Appellees’ Petition for Rehearing

Saw Palmetto / Memorandum in Support of Motion for Summary Judgment

Saw Palmetto/BPH Opposition To Motion To Dismiss

Medicinal Marijuana Application for Preliminary Injunction

Pearson Remand Application for Preliminary Injunction

Pearson Remand Memorandum in Support of Application for Preliminary Injunction

Pearson Remand Memorandum in Support of Motion to Supplement

Pearson Remand Memorandum in Support of Reply to Opposition

Folic Acid Motion for Preliminary Injunction and Memo in Support

Folic Acid / Reply to Opposition to Motion for Summary Judgment

Folic Acid / Reply to Opposition to Application for Preliminary Judgment

Folic Acid / Opposition to Motion to Dismiss

Folic Acid / Opposition to Petition for Reconsideration

Saw Palmetto / Reply to Opposition to Motion for Summary Judgment

Memorandum in Support of Application for Preliminary Injunction in the Antioxidant Case

COMMENTS/PETITIONS:

ANH Comments in re Medicare Revisions to promote Program Efficiency (Apr. 2013)

CBNS Comments in re Medicare Revisions to promote Program Efficiency (Apr. 2013)

AbleChild.org Appeal to Connecticut Freedom of Information Commission (Apr. 2013)

EDA New Dietary Ingredient (NDI) Comments on FDA Guidance Document (Dec. 2011)

EDA New Dietary Ingredient (NDI) Comments on Economic Burden

FDA grants qualified claims for calcium and colon/rectal cancer and polyps

FDA grants qualified claims for calcium and hypertension

Chromium Picolinate Petition Decision

The Coronary Heart Disease Risk Reducing Effects of N-3 Fatty Acids

Connor’s Scientific References

Final Comments on Proposed CGMPs

Comments on Qualified Health Claims

Comments on FDA’s Task Force on Consumer Health Information for Better Nutrition

FTC First Amendment Petition

Ephedra Comments

First Amendment Reply Comments

First Amendment Comments

Saw Palmetto / BPH Health Claim Petition

B-Vitamin / Vascular Disease Health Claim Petition

E-Vitamin / Heart Disease Health Claim Petition

Comments on Proposed GMPs for Dietary Supplements

Comments on Proposed Ephedra Regulations

Petition for Rulemaking Calling on FTC to Define Competent and Reliable Scientific Evidence

Comments to HCFA on Privacy Regulations

Comments on FDA’s Significant Scientific Agreement Standard

Structure/Function Claims Proposed Rule

CONGRESSIONAL TESTIMONY:

Access to Medical Treatment House Government Reform and Oversight Committee

FDA TESTIMONY:

Pearson Implementation

NLEA and Health Claims to Treat or Mitigate Disease Committee

COURT TRANSCRIPTS:

April 10, 2000, Pearson v. Shalala Preliminary Injunction Hearing

October 28, 2002, Whitaker v. Thompson Motions Hearing

SPEECHES:

The Destruction of Solo and Small Group Medical Practices by Medicare (Heritage Foundation)

Speech on FDA Violation of First Amendment (FDLI)

CONTRIBUTIONS:

Individuals and entities interested in making a financial contribution to any of our Litigation Funds should contact:

Jonathan Emord. Emord & Assiciates, P.C.,
11808 Wolf Run Lane
Clifton, VA 20124
(202-466-6937) for additional information.


Whether evaluating a concept, performing regulatory due diligence, maintaining or prosecuting regulatory filings, or contesting adverse litigation, Emord & Associates provides exceptional counsel for all your litigation and regulatory needs.

Virginia (Firm HQ)

11808 Wolf Run Lane
Clifton, VA 20124
Telephone: (202) 466-6937
Telecopier: (202) 466-6938

Arizona

2730 S. Val. Vista Dr.
Bldg. 6, Ste 133
Gilbert, AZ 85295
Telephone: (602) 388-8899
Telecopier: (602) 393-4361